Tenaya Therapeutics, Inc. Employee Benefits and Share-based Compensation
Tenaya Therapeutics, Inc. (TNYA) reported Employee Benefits and Share-based Compensation of $900.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-05
- Tenaya Therapeutics, Inc. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $100.00K.
- Tenaya Therapeutics, Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $100.00K.
- Tenaya Therapeutics, Inc. employee benefits and share-based compensation for the quarter ending 2025-06-30 was $500.00K.
- Tenaya Therapeutics, Inc. employee benefits and share-based compensation for the quarter ending 2025-03-31 was $400.00K.
- Tenaya Therapeutics, Inc. employee benefits and share-based compensation for fiscal 2025 was $1.10M.
| Period end | Employee Benefits and Share-based Compensation | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $900.00K 10-Q · filed 2026-08-05 | ||||
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $200.00K derived: sum of 2 quarters · filed 2026-03-11 | $700.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.10M 10-K · filed 2026-03-11 | |
| 2025-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $600.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.00M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $900.00K 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-06 | ||||
| 2025-02-06 | $1.30M 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |